Daewoong pharmaceutical

069620.KO

103.50 USD

-0.13

-0.13%

Overview

Last close

103.50 usd

Market cap

1.19B usd

52 week high

123.18 usd

52 week low

72.15 usd

Target price

153.88 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.1226

Price/Book Value

1.9909

Enterprise Value

1.60B usd

EV/Revenue

1.4951

EV/EBITDA

15.0993

Key financials

Revenue TTM

1.07B usd

Gross Profit TTM

552.08M usd

EBITDA TTM

157.61M usd

Earnings per Share

N/A usd

Dividend

0.43 usd

Total assets

1.56B usd

Net debt

N/A usd

About

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.